Disc Medicine, Inc. Quarterly Debt-to-equity in % from Q2 2021 to Q3 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Disc Medicine, Inc. quarterly Debt-to-equity history and growth rate from Q2 2021 to Q3 2024.
Disc Medicine, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 5.34 %, a 6.49% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	5.34	-0.37	-6.49%	Sep 30, 2024
Q2 2024	5.09	-2.09	-29.1%	Jun 30, 2024
Q1 2024	4.91	-13.7	-73.6%	Mar 31, 2024
Q4 2023	4.91	+61.3		Dec 31, 2023
Q3 2023	5.7	+16.8		Sep 30, 2023
Q2 2023	7.18	+68		Jun 30, 2023
Q1 2023	18.6	-16.8	-47.4%	Mar 31, 2023
Q4 2022	-56.4	-71.8	-466%	Dec 31, 2022
Q3 2022	-11.1	-28.7	-163%	Sep 30, 2022
Q2 2022	-60.8	-84.1	-361%	Jun 30, 2022
Q1 2022	35.4			Mar 31, 2022
Q4 2021	15.4			Dec 31, 2021
Q3 2021	17.7			Sep 30, 2021
Q2 2021	23.3			Jun 30, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.